Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-13-001811
Filing Date
2013-09-12
Accepted
2013-09-12 18:05:10
Documents
1
Period of Report
2013-09-10

Document Format Files

Seq Description Document Type Size
1 form4-09122013_030901.html 4  
1 form4-09122013_030901.xml 4 7611
  Complete submission text file 0001415889-13-001811.txt   8956
Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONYX PHARMACEUTICALS, INC. 2100 POWELL STREET EMERYVILLE CA 94608
Business Address
Brege Laura (Reporting) CIK: 0001365619 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 131094960